Highland Capital Management (Texas)’s Standard BioTools LAB Stock Holding History

Highland Capital Management (Texas)’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100,000	Closed	-$862K	–	332
2018 Q4	$862K	Buy	+100,000	New	+$779K	0.07%	168
2016 Q1	–	Sell	-269,483	Closed	-$2.91M	–	246
2015 Q4	$2.91M	Sell	269,483 -139,294	-34%	-$1.37M	0.09%	157
2015 Q3	$3.31M	Buy	408,777 +7,432	+2%	+$117K	0.1%	165
2015 Q2	$9.71M	Buy	401,345 +321,126	+400%	+$10.1M	0.2%	123
2015 Q1	$3.38M	Buy	80,219 +67,986	+556%	+$2.69M	0.07%	162
2014 Q4	$413K	Buy	+12,233	New	+$346K	0.01%	197

Other funds holding LAB

EIP

Easterly Investment Partners Beverly, Massachusetts $1.31B AUM 18.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Highland Capital Management (Texas)'s LAB Position: Q1 2019 in Review

Highland Capital Management (Texas) sold out of Standard BioTools (LAB) in Q1 2019, closing a stake of 100,000 shares — an estimated $862K sold.

Highland Capital Management (Texas) first reported a position in LAB in Q4 2014 and held it in 6 quarters. The position peaked at $9.71M in Q2 2015. 131 funds tracked by Wall St. Rank hold LAB as of Q1 2019.

Highland Capital Management (Texas) reported no remaining Standard BioTools position as of Q1 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 100,000 Standard BioTools shares in Q1 2019, an estimated $862K.
Highland Capital Management (Texas) first reported a position in Standard BioTools in Q4 2014 and held it in 6 quarters.
Highland Capital Management (Texas)'s Standard BioTools position peaked at $9.71M in Q2 2015.
131 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q1 2019, filed 15 May 2019.